Cite
HARVARD Citation
Pennell, C. et al. (2022). Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19+ malignancy. Journal for immunotherapy of cancer. 10 (12), p. . [Online].